Rapid method for the construction of Salmonella enterica Serovar Typhimurium vaccine carrier strains.
Salmonella enterica serovar Typhimurium is a versatile organism for the generation of live recombinant vaccines for mucosal immunization. Various strategies have been devised for the stable and efficient expression of heterologous antigens by attenuated S. enterica strains, but these methods often require complex manipulations. Use of phage lambda Red recombinase has recently been devised for gene replacements in Escherichia coli and S. enterica after introduction of PCR products. Based on this method, we have developed an approach that allows the integration of recombinant expression cassettes for heterologous antigens in a single step. The recombinant construct is integrated into the chromosome and is devoid of any selective marker such as antibiotic resistance. We observed the stable expression of model antigens without selective pressure. In addition, the method allows the simultaneous generation of attenuating mutations by gene deletions. The novel "knock-in" approach allows the rapid and efficient construction of recombinant Salmonella strains as vaccine carriers.
Husseiny
Mohamed I
MI
Institut für Klinische Mikrobiologie, Immunologie und Hygiene, FAU Erlangen-Nürnberg, Wasserturmstr. 3-5, D-91054 Erlangen, Germany.
Hensel
Michael
M
D000818:Animals; D001426:Bacterial Proteins / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D001428:Bacterial Vaccines / Q000235:genetics / Q000276:immunology; D010582:Bacteriophage lambda; D002876:Chromosomes, Bacterial / Q000235:genetics; D004926:Escherichia coli / Q000235:genetics; D017353:Gene Deletion; D005821:Genetic Techniques; D005822:Genetic Vectors; D051379:Mice; D008807:Mice, Inbred BALB C; D045522:Recombinases; D011995:Recombination, Genetic; D022562:Salmonella Vaccines / Q000235:genetics / Q000276:immunology; D012486:Salmonella typhimurium / Q000145:classification / Q000235:genetics*; D013601:T-Lymphocytes / Q000276:immunology; D013997:Time Factors; D014611:Vaccination; D014613:Vaccines, Attenuated / Q000235:genetics / Q000276:immunology; D014614:Vaccines, Synthetic; D014774:Virulence / Q000235:genetics
D001426:Bacterial Proteins; D001428:Bacterial Vaccines; D045522:Recombinases; D022562:Salmonella Vaccines; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic
Cell Microbiol. 2003 Dec;5(12):933-45
14641178
Gene. 2002 May 15;290(1-2):153-61
12062810
J Infect Dis. 1975 May;131(5):553-8
1092768
J Bacteriol. 1978 Jun;134(3):1141-56
149110
Nature. 1981 May 21;291(5812):238-9
7015147
J Exp Med. 1983 Apr 1;157(4):1149-69
6601175
Gene. 1990 Mar 30;88(1):57-63
2187747
Gene. 1990 Sep 28;94(1):29-35
2227450
Gene. 1991 Apr;100:195-9
2055470
Res Microbiol. 1990 Sep-Oct;141(7-8):1003-4
2101464
Res Microbiol. 1990 Sep-Oct;141(7-8):797-805
1966252
EMBO J. 1992 Apr;11(4):1309-16
1339343
Mol Microbiol. 1993 Mar;7(6):933-6
8387147
Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2593-7
8637919
Science. 1997 Sep 26;277(5334):2007-11
9302299
Nat Genet. 1998 Oct;20(2):123-8
9771703
Mol Microbiol. 1998 Oct;30(1):163-74
9786193
Infect Immun. 1999 Feb;67(2):700-7
9916080
Infect Immun. 1999 Mar;67(3):1093-9
10024548
Mol Microbiol. 1999 Mar;31(6):1759-73
10209748
Vaccine. 2005 Apr 8;23(20):2580-90
15780440
Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5
10829079
Biol Chem. 2001 Apr;382(4):521-32
11405217
Infect Immun. 2001 Dec;69(12):7493-500
11705925
Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15264-9
11742086
Infect Immun. 2002 Mar;70(3):1403-9
11854226
Appl Environ Microbiol. 2003 Dec;69(12):7480-91
14660401